SEC Company Response from OptimizeRx Corp (OPRX) (CIK 0001448431) (OPRX) — May 23, 2014

OptimizeRx Corp (OPRX) (CIK 0001448431)
Date: May 23, 2014 · CIK: 0001448431 · Accession: 0001255294-14-000505

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-195210

Date

May 22, 2014

Author

Not clearly detected

Form

CORRESP

Company

OptimizeRx Corp (OPRX) (CIK 0001448431)

Letter

Division of Corporation Finance Washington, D.C. 20549-7010 Re: OptimizeRx Corp Registration Statement on Form S-1 File No. 333-195210

Dear Mr. Shuman:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, OptimizeRx Corp (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 to 4:00 PM Eastern Standard Time on May 28, 2014, or as soon thereafter as is practicable.

The Company acknowledges the following:

Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your assistance. Please call with any questions.

OptimizeRx Corp

By:

/s/ David Harrell

David Harrell

Chief Executive Officer

400 Water Street Suite 200

Rochester, MI, 48307- Phone: 248 651-6568

Show Raw Text

CORRESP
1
filename1.htm

OptimizeRx
Corp

May 22, 2014

THE UNITED STATES SECURITIES

AND EXCHANGE COMMISSION

Attn: Mark P. Shuman

Division of Corporation Finance

Mail Stop 7010

100 F. Street NE

Washington, D.C. 20549-7010

Re: OptimizeRx Corp

Registration Statement on Form S-1

File No. 333-195210

Dear Mr. Shuman:

Pursuant to Rule 461 under the Securities Act
of 1933, as amended, OptimizeRx Corp (the “Company”) hereby requests acceleration of the effective date of its Registration
Statement on Form S-1 to 4:00 PM Eastern Standard Time on May 28, 2014, or as soon thereafter as is practicable.

The Company acknowledges the following:

Should the Commission or the staff, acting pursuant to delegated authority,
declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

The action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy
of the disclosure in the filing; and

The Company may not assert staff comments and the declaration of effectiveness
as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your assistance. Please call
with any questions.